The FLOW (Evaluate Renal F unction with Semag l utide O nce W eekly) study is a double-blind, randomised, placebo-controlled international trial comprising 3,533 patients, with a median follow-up period of 3.4 years
The primary culprit is delayed gastric emptyingfood remains in the stomach significantly longer than normal, sometimes for several additional hours
But specific situations make the case even clearer
The food you eat will remain in the stomach a little longer making you feel full sooner and limiting overeating
But at a time when we should be promoting health care access, the health plan for New York City employees recently made a surprising decision with far-reaching repercussions: they announced that they will discontinue coverage of GLP-1 weight loss medicines for its 400,000 public employees
How Does Semaglutide Work For Weight Loss